GENE ONLINE|News &
Opinion
Blog

2020-08-26| COVID-19Special

USFDA Chief Apologizes For Overstating Benefits of Convalescent Plasma Therapy

by Pavel Ryzhov
Share To
Following backlash from critics, FDA chief Stephen Hahn apologized for his remarks that were in agreement with the US President Donald Trump’s claim that convalescent plasma is a powerful therapy for COVID-19. The race against the clock to find a safe and efficacious treatment option against COVID-19 has been ongoing for the last 9 months. The difficulty lies not only in finding the appropriate medical intervention

GO Prime with only $1.49 now

LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top